NCT06574035

Brief Summary

The Michigan Men's Diabetes Project III: Mind \& Motion is an 7-month pilot randomized clinical trial. The investigators are looking to recruit 80 Black men with type 2 diabetes (T2D) (need to have diagnosis for at least one year) that are over the age of 18. Participants also must be under the care of a physician for their diabetes, self report an Hemoglobin A1c (A1C) of 7.0% or more in the last year, be willing to participate in study events (weekly physical activity, exercise and Cognitive Behavioral Therapy (CBT) sessions, group discussion sessions, and in-person health assessments), have reliable internet access (steady internet connection or unlimited data) that will allow them to use a tablet/phone/computer to complete study related tasks, live in the Wayne or Washtenaw County, and have reliable transportation to in-person events. All participants will receive 8 hours/sessions of cognitive behavioral therapy. Participants randomized to the intervention arm will also receive 8 sessions of guided exercise at the same time. Following that they will also receive 8 group discussion sessions that will serve as on-going support. All sessions will be help via Zoom. Additionally, all participants will participate in The 4 health assessments will take place at baseline, 10 weeks, 18 weeks, and 30 weeks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
3mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Jan 2025Sep 2026

First Submitted

Initial submission to the registry

August 21, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 27, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

January 13, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

June 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

August 21, 2024

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in A1C

    Anthropometric/clinical data

    Screening, Baseline, 10 weeks, 18 weeks, 30 weeks

  • Change in General Quality of Life (12-Item Short Form Survey (SF-12))

    Survey Data - 12 questions covering physical and mental health domains - Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health.

    Baseline, 10 weeks, 18 weeks, 30 weeks

  • Change in Diabetes-Related Distress (The Type 2 Diabetes Distress Assessment System)

    Survey Data - The assessment system has two components: The Core Distress Scale and The Sources Scale. The CORE DISTRESS SCORE is simply the average of the 8 items of the CORE SCALE, with each item rated on a 1 to 5 scale: Mean score \< 2.0 indicate little or no distress, Mean score between 2.0 and 2.9 indicate moderate distress, Mean score \> 3.0 indicate high distress. The Sources scale aims to find the sources of the distress, whether CORE DISTRESS is high or low, it is helpful to identify those aspects of living with diabetes that are contributing to the individual's diabetes distress.

    Baseline, 10 weeks, 18 weeks, 30 weeks

  • Change in Diabetes Quality of Life (Diabetes Quality of Life Instrument)

    Survey Data - Survey answers range for each section of the survey asking about satisfaction, worry, and impact of diabetes. The DQoL measure consists of 46 items ranked on a 5-point Likert scale. Individual domain and DQoL total scores range from 0 (lowest possible QoL) to 100 (highest possible QoL).

    Baseline, 10 weeks, 18 weeks, 30 weeks

Secondary Outcomes (1)

  • Change in Diabetes Self-Efficacy (Perceived Diabetes Self-Management Scale)

    Baseline, 10 weeks, 18 weeks, 30 weeks

Other Outcomes (15)

  • Change in Masculinity Ideology (The Conformity to Masculine Norms Inventory-30)

    Baseline, 10 weeks, 18 weeks, 30 weeks

  • Change in BMI

    Baseline, 10 weeks, 18 weeks, 30 weeks

  • Chance in Estimated Abdominal Subcutaneous and Visceral Fat Stores

    Baseline, 10 weeks, 18 weeks, 30 weeks

  • +12 more other outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants randomized to the intervention group will receive 8 one hour virtual sessions of individual cognitive behavioral therapy (CBT) that will take place via U-M Zoom, which is a HIPAA compliant virtual conferencing platform. Participants in this group will also receive 8 one hour virtual sessions of individual exercise. Participants in this group will also receive 8 one hour virtual group discussion sessions that will serve as on-going support. This group (4-8 participants) discussion will be facilitated by one CBT Interventionist and one Exercise Interventionist. These sessions will take place following the individual sessions of CBT and Exercise.

Behavioral: Cognitive Behavioral TherapyBehavioral: ExerciseBehavioral: Group Discussions - Ongoing Support

Control Group

ACTIVE COMPARATOR

Participants randomized to the control group will receive enhanced usual care (EUC). The EUC group will receive 8 sessions of standard Cognitive Behavioral Therapy.

Behavioral: Cognitive Behavioral Therapy

Interventions

Cognitive behavioral therapy focuses on the unique needs of men. A culturally adapted CBT program will be administered to participants as it has demonstrated increased effectiveness for marginalized populations. Cognitive Behavioral Therapy (CBT) aligns well with these cultural needs due to its individualized approach, non-judgmental stance, collaborative nature, and emphasis on empowerment through skills building.

Control GroupIntervention Group
ExerciseBEHAVIORAL

Research demonstrates a preference for physical activity interventions among men with chronic illnesses, while highlighting limited access to fitness facilities in low-income urban areas as a barrier to participation. Online physical activity interventions have shown efficacy and cost-effectiveness in improving health behaviors, with virtual exercise programs for low-income African American populations demonstrating significant reductions in depressive symptoms. Therefore participants will receive exercise to help improve their diabetes self-management behaviors and depressive symptoms.

Intervention Group

Participants will join group discussions that will serve as on-going support. The small group component is designed to foster self-efficacy, autonomous motivation, and enjoyment by integrating skills building, personal values, spirituality, and goal setting. This approach has shown positive outcomes in previous pilot studies with African American men, serving as a source of vicarious learning and social support.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsSelf-representation of gender identity
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American/Black males
  • age 18 years or older
  • ambulatory status
  • diagnosis of Type 2 Diabetes (T2D) for one year duration or longer
  • be under the care of a physician for their diabetes, self report an A1C of 7.0% or more in the last year
  • be willing to participate in study events (weekly physical activity, exercise and CBT sessions, group discussion sessions, and in-person health assessments)
  • have reliable internet access (steady internet connection or unlimited data) that will allow them to use a tablet/phone/computer to complete study related tasks
  • live in the Wayne or Washtenaw County\\
  • have reliable transportation to in-person events

You may not qualify if:

  • stage 2 hypertension as defined by Joint National Committee (JNC) VIII
  • recent cardiac events
  • recent laser surgery for proliferative retinopathy
  • history of stroke
  • lower limb amputation
  • peripheral neuropathy
  • severe Chronic Obstructive Pulmonary Disease (COPD) (e.g., basal oxygen)
  • class III or IV heart failure
  • medical instability.
  • ongoing unstable angina
  • uncontrolled cardiac arrhythmia with hemodynamic compromise
  • active endocarditis
  • symptomatic severe aortic stenosis
  • acute myocarditis or pericarditis
  • acute aortic dissection
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Depression

Interventions

Cognitive Behavioral TherapyExercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jaclynn Hawkins, PhD

    University of Michigan, School of Social Work

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jaclynn Hawkins, PhD

CONTACT

Hannah Burgess, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 21, 2024

First Posted

August 27, 2024

Study Start

January 13, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

June 12, 2026

Record last verified: 2026-03

Locations